Litcius/Paper detail

121P MK-7684A (vibostolimab [vibo] plus pembrolizumab [pembro] coformulation) with/without docetaxel in metastatic NSCLC after platinum-chemotherapy (chemo) and immunotherapy

Nir Peled, Julien Mazières, Dariusz M. Kowalski, W-S. Lam, Maximilian J. Hochmair, Margarita Majem, Se Hoon Kim, Antonio Calles, Kristof Cuppens, Ignacio Casarini, Olivier Bylicki, Byoungyong Shim, Jens Benn Sørensen, Marina Gilli, Soon Hin How, Christian Schumann, Carmen González Arenas, Taiping He, Ayman Samkari, Silvia Novello

2023Immuno-Oncology Technology13 citationsDOIOpen Access PDF

Topics & Concepts

DocetaxelPembrolizumabMedicineChemotherapyImmunotherapyOncologyInternal medicineCancerCancer Immunotherapy and BiomarkersCancer Genomics and DiagnosticsLung Cancer Treatments and Mutations